Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Dev Prasad 's Stock Ratings
LUCID CAPITAL MARKETS Analyst
Dev Prasad is an analyst at LUCID CAPITAL MARKETS. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/30/2025
Overall Average Return
-53.9%
Smart Score
Overall Average Return Percentile
2nd
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/17/2024 | AVTX | Buy Now | Avalo Therapeutics | $4.97 | 382.85% | Dev Prasad 8% | → $24 | Initiates | → Buy | Get Alert |
| 12/17/2024 | IBIO | Buy Now | iBio | $1.05 | 471.43% | Dev Prasad 8% | → $6 | Initiates | → Buy | Get Alert |
| 12/17/2024 | CALC | Buy Now | CalciMedica | $1.61 | 707.45% | Dev Prasad 8% | → $13 | Initiates | → Buy | Get Alert |
